Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 13, No. 5-6, 2006   

Free Abstract     Article (References)     Article (PDF 423 KB)     

Paper

From the Brain-Skin Connection: The Neuroendocrine-Immune Misalliance of Stress and Itch
Petra Arcka, Ralf Pausb

aCenter for Internal Medicine and Dermatology, Charité, University Medicine Berlin, Berlin, and
bDepartment of Dermatology, University Hospital Schleswig-Holstein, University of Lübeck, Lübeck, Germany

Address of Corresponding Author

Neuroimmunomodulation 2006;13:347-356 (DOI: 10.1159/000104863)


 goto top of page Key Words

  • Stress
  • Pruritus
  • Neurogenic inflammation
  • Mast cells
  • Skin
  • Immunodermatoses

 goto top of page Abstract

Perceived stress has long been allied with disturbances of the dynamic equilibrium established between the nervous, endocrine and immune systems, thus triggering or aggravating disease manifestation. Several common skin diseases are now acknowledged to be worsened by psychological stress, particularly immunodermatoses such as atopic dermatitis, psoriasis, seborrheic eczema, prurigo nodularis, lichen planus, chronic urticaria, alopecia areata and pruritus sine materia. Itch (pruritus) is perhaps the most common symptom associated with a majority of these inflammatory skin diseases, and acute as well as chronic stress perceptions are recognized to trigger or enhance pruritus. A wealth of mediators released systemically or locally in the skin in response to stress increase sensory innervation, upregulate the production of other pruritogenic agents, perpetuate (neurogenic) inflammation and lower the itch threshold. In the present review, we explore recent frontiers in both stress and pruritus research and portray the perpetuation of chronic skin inflammation and itch as a neuroendocrine-immune 'misalliance'. We argue that key candidate molecules of the stress response with strong pruritogenic potential, such as nerve growth factor, corticotropin-releasing hormone and substance P, and mast cells, which may be considered as 'central cellular switchboards of pruritogenic inflammation', need to be further explored systematically in order to develop more effective therapeutic combination strategies for itch management in chronic, stress-vulnerable inflammatory skin diseases

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Petra Arck, MD
AG PsychoNeuroImmunologie, Med. Klinik mit Schwerpunkt Psychosomatik
Charité, Campus Virchow, Forum 4, Raum 2.0549
Augustenburger Platz 1, DE-13353 Berlin (Germany)
Tel. +49 30 450 553 873, Fax +49 30 450 553 962, E-Mail petra.arck@charite.de


 goto top of page Article Information

Published online: August 6, 2007
Number of Print Pages : 10
Number of Figures : 2, Number of Tables : 1, Number of References : 53

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17709957)
Download Citation
Cited In



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel